Ticker Scorecard - ACLX Basics Company: Arcellx, Inc. Common Stock IPO Date: February 4, 2022 Sector: Healthcare Industry: Biotech Market Cap: $3.45B Activated in VL: True Average Daily Range Avg Daily Range: $1.08 | 2.81% Avg Daily Range (30 D): $1.41 | 2.10% Avg Daily Range (90 D): $2.11 | 2.55% Institutional Daily Volume Avg Daily Volume: .4M Avg Daily Volume (30 D): .56M Avg Daily Volume (90 D): .5M Trade Size Avg Trade Size (Sh.): 54 Avg Trade Size (Sh.) (30 D): 50 Avg Trade Size (Sh.) (90 D): 45 Institutional Trades Total Inst.Trades: 1,602 Avg Inst. Trade: $2.45M Avg Inst. Trade (30 D): $2.27M Avg Inst. Trade (90 D): $3.05M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.72M Avg Closing Trade (30 D): $3.94M Avg Closing Trade (90 D): $5.93M Avg Closing Volume: 78.87K     News Feb 12, 2025 @ 8:22 PM Gilead Ups 2025 Outlook, Eyes Lenacapavir Launch F... Source: Vandana Singh May 31, 2024 @ 12:01 PM Expert Ratings For Arcellx Source: Benzinga Insights May 14, 2024 @ 12:01 PM Analyst Expectations For Arcellx's Future Source: Benzinga Insights May 9, 2024 @ 9:10 PM Arcellx, Inc. (ACLX) Reports Q1 Loss, Tops Revenue... Source: Zacks Equity Research May 1, 2024 @ 9:20 PM Sarepta Therapeutics (SRPT) Q1 Earnings and Revenu... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.71 $-.48 $-.51 Diluted EPS $-.71 $-.48 $-.51 Revenue $ 155.82M $ 26.03M $ 27.38M Gross Profit $ $ $ Net Income / Loss $ -40.42M $ -25.87M $ -27.2M Operating Income / Loss $ -69.42M $ -33.62M $ -34.99M Cost of Revenue $ $ $ Net Cash Flow $ 33.42M $ 61.82M $ -54.55M PE Ratio